Filing Details
- Accession Number:
- 0001384101-18-000080
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-11-01 17:07:24
- Reporting Period:
- 2018-10-31
- Accepted Time:
- 2018-11-01 17:07:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1384101 | Veracyte Inc. | VCYT | Services-Medical Laboratories (8071) | 205455398 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1449535 | M Christopher Hall | 6000 Shoreline Court Suite 300 South San Francisco CA 94080 | President And Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-10-31 | 3,500 | $2.36 | 35,955 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-10-31 | 3,500 | $13.00 | 32,455 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-10-31 | 16,927 | $2.68 | 49,382 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-10-31 | 16,500 | $13.02 | 32,882 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-10-31 | 427 | $14.00 | 32,455 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-10-31 | 19,573 | $2.68 | 52,028 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-10-31 | 19,573 | $14.00 | 32,455 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Acquisiton | 2018-10-31 | 3,500 | $0.00 | 3,500 | $2.36 |
| Common Stock | Stock Option (right to buy) | Acquisiton | 2018-10-31 | 16,927 | $0.00 | 16,927 | $2.68 |
| Common Stock | Stock Option (right to buy) | Acquisiton | 2018-10-31 | 19,573 | $0.00 | 19,573 | $2.68 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2021-02-22 | No | 4 | M | Direct | |
| 0 | 2022-03-09 | No | 4 | M | Direct | |
| 813 | 2022-03-09 | No | 4 | M | Direct |
Footnotes
- The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 25, 2018.
- Represents the aggregate of sales effected on the same day at different prices.
- Represents weighted average sales price. Sale prices for the transactions range from $13.00 to $13.08. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
- The option became exercisable upon the grant date.
- The option becomes exercisable as to 25% of the shares on March 10, 2013, and the remaining shares vested at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
Billionaire Hedge Funds
